Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014796166> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2014796166 endingPage "111S" @default.
- W2014796166 startingPage "104S" @default.
- W2014796166 abstract "Studies of primary prophylaxis of febrile neutropenia (FN) with recombinant human granulocyte colony-stimulating factor (rHu-G-CSF, filgrastim) administered to all patients starting their initial course of chemotherapy have demonstrated clinical effectiveness and an economic advantage in a wide range of settings. A recent meta-analysis confirmed the ability of filgrastim to reduce the risk of FN and documented infection in a variety of malignancies in both adults and children. The threshold risk for FN at which a cost saving is achieved by using filgrastim is inversely related to the daily cost of the drug and duration of hospitalization. Clinical practice guidelines for the use of filgrastim were developed based on these observations. Recent studies incorporating indirect institutional costs demonstrated that a cost saving can be achieved at substantially lower FN risk thresholds than previously estimated. Despite the demonstrated efficacy of filgrastim in primary prophylaxis, its value may be further increased by appropriately selecting patients and better understanding the importance of sustaining dose intensity in specific malignancies. Clinical prediction models capable of identifying individuals at high risk for neutropenic complications yield further reductions in FN risk thresholds and treatment costs in patients receiving cancer chemotherapy. These models also may be used to evaluate the cost-effectiveness or cost-efficiency of filgrastim. A clinical prediction model recently was presented and validated incorporating both baseline clinical characteristics as well as the results of the first cycle of chemotherapy in patients with early-stage breast cancer. A cost-effectiveness ratio of $34,297/year of life saved was estimated based on dose-response assumptions derived from a previously reported adjuvant breast cancer trial studying the impact of dose reduction on disease-free survival. The cost-effectiveness of filgrastim was evident over a wide range of clinical and cost assumptions. Clinical prediction models permit the rational and cost-effective identification of patients for filgrastim support. Existing clinical practice guidelines should be reevaluated in light of new information available on both the total costs associated with FN as well as the cost-effectiveness of these agents in patients receiving chemotherapy for sensitive and potentially curable malignancies." @default.
- W2014796166 created "2016-06-24" @default.
- W2014796166 creator A5073060840 @default.
- W2014796166 date "2000-07-01" @default.
- W2014796166 modified "2023-09-23" @default.
- W2014796166 title "A Predictive Model for Neutropenia Associated with Cancer Chemotherapy" @default.
- W2014796166 cites W160475964 @default.
- W2014796166 cites W1868843221 @default.
- W2014796166 cites W1966140433 @default.
- W2014796166 cites W202042235 @default.
- W2014796166 cites W2027096672 @default.
- W2014796166 cites W2057816237 @default.
- W2014796166 cites W2074454485 @default.
- W2014796166 cites W2114046957 @default.
- W2014796166 cites W2136802843 @default.
- W2014796166 cites W2154011558 @default.
- W2014796166 cites W2248478085 @default.
- W2014796166 cites W2339773433 @default.
- W2014796166 cites W2341557816 @default.
- W2014796166 cites W2750811080 @default.
- W2014796166 cites W4237434210 @default.
- W2014796166 cites W4247585355 @default.
- W2014796166 cites W4362046093 @default.
- W2014796166 doi "https://doi.org/10.1592/phco.20.10.104s.35232" @default.
- W2014796166 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10905685" @default.
- W2014796166 hasPublicationYear "2000" @default.
- W2014796166 type Work @default.
- W2014796166 sameAs 2014796166 @default.
- W2014796166 citedByCount "28" @default.
- W2014796166 crossrefType "journal-article" @default.
- W2014796166 hasAuthorship W2014796166A5073060840 @default.
- W2014796166 hasConcept C112930515 @default.
- W2014796166 hasConcept C126322002 @default.
- W2014796166 hasConcept C141071460 @default.
- W2014796166 hasConcept C143998085 @default.
- W2014796166 hasConcept C177713679 @default.
- W2014796166 hasConcept C2776694085 @default.
- W2014796166 hasConcept C2777063308 @default.
- W2014796166 hasConcept C2777767877 @default.
- W2014796166 hasConcept C2778850193 @default.
- W2014796166 hasConcept C2779171977 @default.
- W2014796166 hasConcept C3019080777 @default.
- W2014796166 hasConcept C535046627 @default.
- W2014796166 hasConcept C71924100 @default.
- W2014796166 hasConceptScore W2014796166C112930515 @default.
- W2014796166 hasConceptScore W2014796166C126322002 @default.
- W2014796166 hasConceptScore W2014796166C141071460 @default.
- W2014796166 hasConceptScore W2014796166C143998085 @default.
- W2014796166 hasConceptScore W2014796166C177713679 @default.
- W2014796166 hasConceptScore W2014796166C2776694085 @default.
- W2014796166 hasConceptScore W2014796166C2777063308 @default.
- W2014796166 hasConceptScore W2014796166C2777767877 @default.
- W2014796166 hasConceptScore W2014796166C2778850193 @default.
- W2014796166 hasConceptScore W2014796166C2779171977 @default.
- W2014796166 hasConceptScore W2014796166C3019080777 @default.
- W2014796166 hasConceptScore W2014796166C535046627 @default.
- W2014796166 hasConceptScore W2014796166C71924100 @default.
- W2014796166 hasIssue "7 Part 2" @default.
- W2014796166 hasLocation W20147961661 @default.
- W2014796166 hasLocation W20147961662 @default.
- W2014796166 hasOpenAccess W2014796166 @default.
- W2014796166 hasPrimaryLocation W20147961661 @default.
- W2014796166 hasRelatedWork W136411592 @default.
- W2014796166 hasRelatedWork W2032853726 @default.
- W2014796166 hasRelatedWork W2048644178 @default.
- W2014796166 hasRelatedWork W2051360772 @default.
- W2014796166 hasRelatedWork W2053128632 @default.
- W2014796166 hasRelatedWork W2102925359 @default.
- W2014796166 hasRelatedWork W2158561707 @default.
- W2014796166 hasRelatedWork W2210770651 @default.
- W2014796166 hasRelatedWork W2367469818 @default.
- W2014796166 hasRelatedWork W4250026301 @default.
- W2014796166 hasVolume "20" @default.
- W2014796166 isParatext "false" @default.
- W2014796166 isRetracted "false" @default.
- W2014796166 magId "2014796166" @default.
- W2014796166 workType "article" @default.